Perioperative GABA Blood Concentrations in Infants with Cyanotic and Non-Cyanotic Congenital Heart Diseases
- PMID: 34202425
- PMCID: PMC8304774
- DOI: 10.3390/diagnostics11071149
Perioperative GABA Blood Concentrations in Infants with Cyanotic and Non-Cyanotic Congenital Heart Diseases
Abstract
Perioperative stress detection in children with congenital heart disease (CHD), particularly in the brain, is still limited. Among biomarkers, γ-amino-aminobutyric acid (GABA) assessment in biological fluids appears to be promising for its regulatory action on the cardiovascular and cerebral systems. We aimed to investigate cyanotic (C) or non-cyanotic (N) CHD children for GABA blood level changes in the perioperative period. We conducted an observational study in 68 CHD infants (C: n = 33; N: n = 35) who underwent perioperative clinical, standard laboratory and monitoring parameter recordings and GABA assessment. Blood samples were drawn at five predetermined time-points before, during and after surgery. No significant perioperative differences were observed between groups in clinical and laboratory parameters. In C, perioperative GABA levels were significantly lower than N. Arterial oxygen saturation and blood concentration significantly differed between C and N children and correlated at cardiopulmonary by-pass (CPB) time-point with GABA levels. The present data showing higher hypoxia/hyperoxia-mediated GABA concentrations in C children suggest that they are more prone to perioperative cardiovascular and brain stress/damage. The findings suggest the usefulness of further investigations to detect the "optimal" oxygen concentration target in order to avoid the side effects associated with re-oxygenation during CPB.
Keywords: GABA; brain; cardiopulmonary by-pass; children; cooling; newborn; reoxygenation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
S100B increases in cyanotic versus noncyanotic infants undergoing heart surgery and cardiopulmonary bypass (CPB).J Matern Fetal Neonatal Med. 2019 Apr;32(7):1117-1123. doi: 10.1080/14767058.2017.1401604. Epub 2017 Nov 28. J Matern Fetal Neonatal Med. 2019. PMID: 29183208
-
Glutathione Blood Concentrations: A Biomarker of Oxidative Damage Protection during Cardiopulmonary Bypass in Children.Diagnostics (Basel). 2019 Sep 13;9(3):118. doi: 10.3390/diagnostics9030118. Diagnostics (Basel). 2019. PMID: 31540197 Free PMC article.
-
Uncontrolled reoxygenation by initiating cardiopulmonary bypass is associated with higher protein S100 in cyanotic versus acyanotic patients.Thorac Cardiovasc Surg. 2000 Oct;48(5):263-8. doi: 10.1055/s-2000-7879. Thorac Cardiovasc Surg. 2000. PMID: 11100757
-
[Effect of sodium acetate Ringer injection on perioperative fluid therapy in children with cyanotic congenital heart disease].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Mar;31(3):363-366. doi: 10.3760/cma.j.issn.2095-4352.2019.03.021. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 30914102 Clinical Trial. Chinese.
-
Hypoxia, reoxygenation and the role of systemic leukodepletion in pediatric heart surgery.Perfusion. 2001 Mar;16 Suppl:19-29. doi: 10.1177/026765910101600i104. Perfusion. 2001. PMID: 11334203 Review.
Cited by
-
Identification of SOX18 as a New Gene Predisposing to Congenital Heart Disease.Diagnostics (Basel). 2022 Aug 8;12(8):1917. doi: 10.3390/diagnostics12081917. Diagnostics (Basel). 2022. PMID: 36010266 Free PMC article.
References
-
- Ottaviani G., Buja L.M. Congenital heart disease: Pathology, natural history, and interventions. In: Buja L.M., Butany J., editors. Cardiovascular Pathology. 4th ed. Academic Press/Elsevier; Waltham, MA, USA: 2016. pp. 611–647.
-
- Gazzolo D., Abella R., Marinoni E., Di Iorio R., Li Volti G., Galvano F., Pongiglione G., Frigiola A., Bertino E., Florio P. Circulating biochemical markers of brain damage in infants complicated by ischemia reperfusion injury. Cardiovasc. Hematol. Agents. Med. Chem. 2009;7:108–126. doi: 10.2174/187152509787847119. - DOI - PubMed
-
- Abella R., Varrica A., Satriano A., Tettamanti G., Pellisero G., Gavilanes A.D., Zimmermann L.J., Hans J.V., Strozzi M.C., Pluchinotta F.R., et al. Biochemical markers for brain injury monitoring in children with or without congenital heart diseases. CNS Neurol. Disord. Drug. Targets. 2015;14:12–23. doi: 10.2174/1871527314666150116114648. - DOI - PubMed
LinkOut - more resources
Full Text Sources